759 / 1708
Group IIA RMS (+ Margin) Favorable Sites
N Chemotherapy Radiotherapy Local Failure
D9602
62
VA
36 Gy
15%
IRS-III
52
VA
41.4 Gy
11%
IRS-IV
43
VAC/VAI/VIE
41.4 Gy
2%
Breneman J et al. Int J Radiat Oncol Biol Phys 2012; 83:720-6